Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
AXL mediates resistance to cetuximab therapy.
Hematoma Locations Predicting Delirium Symptoms After Intracerebral Hemorrhage.
Natural polyphenols enhanced the Cu(II)/peroxymonosulfate (PMS) oxidation: The contribution of Cu(III) and HO•.
Treatment Approaches for Oligoprogressive Non-Small Cell Lung Cancer: A Review of Ablative Radiotherapy.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
AXL mediates resistance to cetuximab therapy.
AXL mediates resistance to cetuximab therapy. Cancer Res. 2014 Sep 15; 74(18):5152-64.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Cell Growth Processes
Cell Line, Tumor
Cetuximab
Drug Resistance, Neoplasm
Head and Neck Neoplasms
Humans
Lung Neoplasms
Mice
Mice, Nude
Proto-Oncogene Proteins
Receptor Protein-Tyrosine Kinases
RNA, Small Interfering
Transfection
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia